27/02/2026
🤝✨🔬 COLLABORATION DRIVES NEW CANCER TRIALS AND TRAINING PATHWAYS 🤝✨🔬
Clinicians from the Northern Sydney Local Health District (NSLHD) and the world-renowned Memorial Sloan Kettering Cancer Center in New York held a half-day summit to discuss their ongoing clinical trials partnership, which is working to change outcomes for cancer patients.
The program at the Royal North Shore Hospital campus featured a series of presentations highlighting the collaboration, current cancer research, and potential future directions.
NORTH STAR VNP is a partnership between NSLHD and MSK, established in 2024 as a new clinical trials research centre following a transformative $20 million donation from Greg Poche AO and the late Kay Van Norton Poche AO. Since its founding, the centre has grown to support 17 active clinical trials across a broad range of tumour types.
NSLHD Chief Executive Anthony Schembri said the international collaboration with MSK was a major pillar of the district’s cancer research strategy. “The clinical trials program across NSLHD is entering a period of significant maturity and acceleration,” he said. “Clinical teams across both organisations remain engaged, with many collaborative studies currently active.”
Dr Pedram Razavi, a breast oncologist and Director of MSK’s Translational Oncology Partnership Program, said working with NSLHD had helped inform other global collaborations, including a new cancer project in Brazil.
Read more: https://bit.ly/4tViPqg